Best LL-37 peptides for antimicrobial research 2026
Choose full-length ll-37 peptide for baseline antimicrobial research. Compare material specifications, purity evidence, endotoxin testing,
Best overall: native humanin peptide for sequence-matched studies. Best for analogue comparisons: S14G-humanin, also called HNG. Best for probing IGFBP-3 interactions: HNGF6A. This 2026 guide compares research constructs, not supplier products, and explains which documentation you need before selecting a reagent.
Selecting a humanin construct changes the experimental question. Native humanin, HNG, and HNGF6A are related reagents, but sequence changes prevent you from treating them as interchangeable controls.
Humanin research includes investigations of cellular stress and survival. Those endpoints do not establish lifespan extension, and a change in cell viability does not establish a mechanism by itself. Your 2026 protocol should state whether it measures survival, mitochondrial function, senescence-associated features, or another defined outcome.
Before comparing suppliers, review the distinction between identity and purity in this peptide purity testing guide. A clean chromatogram cannot resolve every question about a reagent.
All compounds discussed here are for research use only, not for human or veterinary administration.
Use these criteria before choosing a construct or reviewing a supplier's quality claims:
A 2026 purchasing decision should begin with sequence and documentation, not the strongest activity claim. Higher reported activity in one model does not make an analogue the correct reagent for every model.
| Rank and construct | Best for | Standout feature | Key limitation |
|---|---|---|---|
| 1. Native humanin | Unmodified-sequence studies | Reference point for comparing humanin analogues | Does not substitute for a modified construct used in a published protocol |
| 2. S14G-humanin, or HNG | Analogue-response comparisons | Glycine replaces serine at residue 14 | Results cannot automatically be assigned to native humanin |
| 3. HNGF6A | IGFBP-3 interaction experiments | Adds an alanine substitution at residue 6 to the HNG background | Requires controls that separate binding effects from other biological effects |
These are molecular options, not verified listings from a supplier catalog. Select the construct first; then establish whether a supplier's documentation matches that exact material.
Native humanin is a peptide of 24 amino-acid residues associated with research into cellular stress and survival. It provides the unmodified-sequence starting point when your question concerns humanin rather than a substituted analogue.
Choose native humanin when reproducing a study that explicitly used that sequence. Confirm the terminal chemistry as well: a matching abbreviated name does not establish that every chemical detail matches the published reagent.
Native humanin pros:
Native humanin cons:
Best for: Researchers establishing a native-humanin baseline or reproducing an unmodified-sequence experiment.
For your 2026 study, define the biological endpoint before selecting an exposure scheme. A viability assay, a mitochondrial measurement, and a senescence-associated readout answer different questions; none should silently stand in for the others.
Verdict: Buy native humanin when the unmodified sequence is your experimental target.
S14G-humanin, commonly abbreviated HNG, replaces serine with glycine at residue 14. HNG retains a length of 24 amino-acid residues, but the substitution makes it a distinct experimental reagent.
HNG is useful when your study explicitly compares humanin analogues or follows an HNG-based protocol. Do not select it merely because an activity description sounds stronger: activity depends on the assay, model, exposure conditions, and endpoint.
HNG pros:
HNG cons:
Best for: Researchers comparing native humanin with a defined substituted analogue.
Use matched experimental conditions when the purpose is to compare constructs. Document differences in vehicle, preparation, and measured peptide content rather than allowing those differences to become hidden explanations for a response.
Verdict: Buy HNG for an HNG-specific protocol or a controlled analogue comparison; skip it as an undocumented substitute.
HNGF6A combines the HNG substitution with replacement of phenylalanine by alanine at residue 6. This construct also contains 24 amino-acid residues and is relevant to research examining humanin interactions with insulin-like growth factor-binding protein-3, or IGFBP-3.
The construct belongs in a mechanism-focused design. Selecting HNGF6A does not, by itself, prove that an observed response is independent of IGFBP-3; your experiment must test that interpretation.
HNGF6A pros:
HNGF6A cons:
Best for: Researchers testing an explicit hypothesis about humanin–IGFBP-3 interactions.
For a 2026 mechanism study, write the competing explanations before collecting data. A response difference could reflect the intended interaction, another sequence-dependent effect, or an analytical problem; choose controls that distinguish those explanations.
Verdict: Buy HNGF6A for a defined interaction hypothesis; skip it for an unspecified cellular-longevity screen.
The ranking prioritizes experimental fit, sequence clarity, analytical verification, and interpretability. Native humanin is the default because it answers the unmodified-sequence question; HNG and HNGF6A occupy separate, narrower use cases.
This is not a ranking of supplier performance or a claim that one construct produces better longevity outcomes. No comparative supplier testing or product-specific humanin documentation underpins those conclusions.
The scientific context includes Hashimoto and colleagues' 2001 PNAS report identifying humanin through an Alzheimer's-related cellular research model, and Ikonen and colleagues' 2003 PNAS investigation of humanin–IGFBP-3 interactions. Their scope is cellular and mechanistic research, not proof of human lifespan extension.
Use a documentation-first sequence for your 2026 procurement review. Each stage resolves a different uncertainty, so a strong result at one stage does not eliminate the others.
A chromatographic purity percentage describes the result of a particular analytical method. It does not automatically report peptide content by mass, exclude every contaminant, or demonstrate sterility. Ask which measurements support the properties your assay actually requires.
Also distinguish a research reagent from a qualified reference standard. A supplier's research-use designation does not establish suitability for calibration, quantitative method validation, or another reference-standard application.
Celonyx Labs describes its research peptides as 99%-pure and third-party-tested. Those are relevant quality signals, but construct-specific selection still requires the corresponding sequence, lot records, and analytical evidence.
Celonyx Labs is best suited to laboratory researchers sourcing research-use-only peptides. The brand's stated focus matches that audience; it does not establish the identity or suitability of a particular humanin construct.
A cellular-longevity label is too broad to function as an endpoint. Write down what you will measure and what that measurement can establish before introducing a humanin peptide.
Use a vehicle control to evaluate the preparation medium. Add appropriate assay controls and, when comparing constructs, account for differences in concentration assignment and sample handling. Record the basis for concentration calculations; vial contents and analytically determined peptide content are not automatically equivalent.
For mitochondrial measurements, assess whether changes track cell number or viability rather than assuming a direct mitochondrial mechanism. For senescence-related work, distinguish the measured marker from a general claim about cellular aging.
Finally, retain the preparation record alongside the result. Sequence, lot, solvent, preparation date, and handling history make a response easier to interpret and a follow-up experiment easier to reproduce.
Choose native humanin if you need a default for an unmodified-sequence study. Choose HNG when the hypothesis or reference protocol specifies the S14G analogue. Reserve HNGF6A for a design that explicitly addresses its additional substitution and interaction context.
For 2026 procurement, reject any option whose documentation cannot establish the construct you need. An attractive purity statement cannot compensate for a sequence mismatch.
What’s the best humanin peptide for cellular longevity research?
Native humanin is the default for studies requiring the unmodified sequence. HNG and HNGF6A fit specific analogue or interaction questions; none establishes human longevity benefits from cellular results alone.
Is HNG the same as native humanin?
No. HNG replaces serine with glycine at residue 14, so it is a distinct construct that requires explicit identification in your protocol.
When should a laboratory choose HNGF6A?
Choose HNGF6A when the study specifically examines its sequence modification or humanin–IGFBP-3 interaction context. Include controls that test the proposed mechanism rather than inferring it from viability alone.
Does 99% purity prove a humanin peptide is suitable for my assay?
No. A purity result does not independently establish identity, biological activity, sterility, or assay compatibility. Review the method and lot-specific supporting records.
Can native humanin and HNG be substituted in a published protocol?
Not without changing the experimental design. Match the published construct or describe the substitution as a deliberate modification requiring validation.
Does humanin research prove anti-aging benefits in people?
No. Cellular and mechanistic findings do not establish human lifespan extension or justify personal use. These reagents are for research use only.
What documentation should I request before selecting a humanin reagent?
Request the complete sequence, terminal chemistry, lot-linked certificate, identity evidence, purity method, and handling information. Add assay-specific requirements such as endotoxin or sterility evidence when your study requires them.
A stronger signal can make the wrong reagent look like the right choice. If your hypothesis concerns native humanin, substituting an analogue changes the question even when the assay response becomes easier to detect. Freeze the construct specification before reviewing response data.
Choose full-length ll-37 peptide for baseline antimicrobial research. Compare material specifications, purity evidence, endotoxin testing,
Choose native VIP peptide for neuroinflammation research. Compare reference standards, labeled tracers, and PACAP-38, with
Buy kisspeptin-10 for laboratory research with a clear selection checklist. Compare material types, verify batch
FOR RESEARCH USE ONLY. Products sold by Celonyx Labs are intended exclusively for laboratory and scientific research. They are not intended for human or veterinary use, consumption, diagnosis, treatment, cure, or prevention of any disease. By purchasing from this site, you acknowledge that you understand the intended research purpose of these materials and agree to comply with all applicable laws and regulations.